Former Biogen exec joins Sanofi executive committee

French pharma major Sanofi (Euronext: SAN) today announced the appointment of Kathleen Tregoning as a new member of the executive committee, effective February 27, 2017. Ms Tregoning joins Sanofi from Biogen where she served as senior vice president of corporate affairs.

Ms Tregoning will lead Sanofi's external affairs organization which is comprised of market Choose access, public affairs, government affairs, corporate communications, global policy and corporate social responsibility.

"Kathleen brings a unique set of talents and experience to Sanofi that combines a deep political and policy expertise with highly relevant corporate experience in the biopharmaceutical industry" said Olivier Brandicourt, chief executive of Sanofi, adding: "Working closely with the entire executive leadership team, Kathleen will lead our efforts to drive a better understanding of the value of our innovations among external stakeholders and ensure appropriate market access for our various healthcare offerings."